Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Paper-Based Devices for Far-Forward Multiplex Diagnostics

by Global Biodefense Staff
November 12, 2014

The Defense Threat Reduction Agency (DTRA) is interested in proposals for applied research to characterize and analyze the critical properties of vertical flow proteomic paper substrates for use in Point of Need (PON) far-forward diagnostic and surveillance (FFDS) devices.

Such devices would be used for the multiplex identification of biological or chemical threat agents.

To address limitations of lateral flow immunoassays, researchers have recently developed sensitive flow-through assays in which samples and reagents are applied vertically. In addition, printing technology is starting to replace array spotting and could enable improved assays.

DTRA seeks a systematic analysis of critical parameters needed to provide a “rules-based” development platform. While improved sensitivity has been demonstrated in a limited proof-of-principle study using Vertical Flow ligand binding format, this BAA effort solicits for a well-controlled, systematic identification of the critical parameters.

In the context of a multiplex identification or typing assay, guard-band studies or design of experiments evaluation of such characteristic are sought:

  • Flow Rate
  • Flow Pressure
  • Filter Paper Grades
  • Membrane Porosity
  • Buffer Formulation
  • Ph/Ionic Strength
  • Antibody/Ligand Printing Concentrations
  • Specific Activity
  • Binding Constants

Proposals are sought as part of DTRA Broad Agency Announcement: HDTRA1-14-CHEM-BIO-BAA. The deadline to submit questions is Dec. 3. Initial proposals are due by Dec. 22, 2014.

Tags: BAADefense Threat Reduction Agency

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC